Multivariate analysis adjusted for age, lymph node metastasis, size and grade of tumor also revealed that methylation of the BRCA1 promoter was an independent prognostic marker for survival in early-stage breast cancer (OS, p = 0.027; DFS, p = 0.003). This evidence concerns the gene BRCA1 and metastatic malignant neoplasm in the lymph nodes.